Mark N. Lampert, 10% Owner at Capstone Therapeutics Corp. (CAPS), bought 252,600 shares at $0.25 ($63K) on 2011-07-20, disclosed to the SEC on 2011-07-22.
Open-market purchase of $63k CAPS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 58,500 | $15K | 23.2% |
| 2 | $0.25 | 194,100 | $49K | 76.8% |
| Total | $0.25 avg | 252,600 | $63K | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |